Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

NCT02285062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse

Interventions

DRUG: lenalidomide
DRUG: Placebo
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: prednisone
DRUG: vincristine

Sponsor

Celgene